February 20th, 2022
Sunday
18:00
GMT
Free
Registration is required
Certification
To all attendants via email
“February 20th, 2022 at 18:00 GMT”
New York
13:00
GMT/London
18:00
Athens
20:00
San Diego
10:00
CEST/Paris, Rome
19:00
Beijing
02:00 (21/02)
The Webinar continues the series of MSc Webinars – the online-ZOOM events for the clinicians and educators in the field of psychiatry.
The MSc Webinar is organized for mental health professionals by the Faculty of Medicine, School of Health Sciences and Medical School of the Aristotle University of Thessaloniki, under the auspices of:
WPA 2020-23 Action Plan group on Evidence Based Psychopharmacology
WPA section on Evidence Based Psychiatry
The aim of these educational sessions is to provide a global and comprehensive update of the newest developments in neurobiology, psychopharmacology, treatment guidelines and personcentered care of mental disorders.
The strategic approach of the invited speakers is to avoid content-free eloquence and authority and to face hard questions on the base of research findings.
SPEAKERS
Prof. Charles B. Nemeroff
"The Status of Laboratory Testing to Predict Antidepressant
Response: Problems & Promises"
Charles B. Nemeroff, MD, PhD is Professor and Chair of the Department of Psychiatry and Behavioral Sciences at the Dell Medical School, University of Texas at Austin. He also directs the Institute for Early Life Adversity Research within the Department of Psychiatry as part of the Mulva Clinic for the Neurosciences. Prior to joining Dell Med, Dr. Nemeroff was chair of the Department of Psychiatry and Behavioral Sciences and clinical director of the Center on Aging at the University of Miami Miller School of Medicine in Miami, Florida. He received his medical degree and doctorate degrees in neurology from the University of North Carolina (UNC) School of Medicine.
Dr. Nemeroff has received a number of research and education awards including the Mrazek Award in Psychiatric Pharmacogenomics, Kempf Award in Psychobiology, the Samuel Hibbs Award, Research Mentoring Award, Judson Marmor Award and the Vestermark Award from the American Psychiatric Association (APA), the Mood Disorders Award, Bowis Award and Dean Award from the ACP and the Julius Axelrod Award for mentoring from the ACNP.
Prof. Konstantinos N. Fountoulakis
"The CINP guidelines for the treatment of Bipolar disorder: An example of evidence-based guidance"
Konstantinos N. Fountoulakis, MD, is Professor of Psychiatry at Aristotle University of Thessaloniki, AHEPA University Hospital, in Thessaloniki, Greece
He is currently, zonal 8 representative (South Europe) in the Board of the World Psychiatric Association, National Representative for Mental Health in the World Health Organization and Vice-President of the Hellenic Psychiatric Association. He chairs the Mental Health Section of the Institute of Scientific Research of the Greek Medical Association.
For the years 2020-1 he served as director of Cochrane Greece.
Dr. Fountoulakis’ areas of clinical and research interest are reflected in the topics that he teaches: general psychiatry, biological psychiatry, psychopharmacology, mood disorders, schizophrenia and personality disorders. He has coauthored more than 400 papers and more than 250 of them are published in international journals such as the LANCET, BMJ, Am J Psychiatry, British Journal of Psychiatry, Biological Psychiatry, International Journal of Neuropsychopharmacology, Journal of Affective Disorders, Schizophrenia Research, Psychiatry Research, Bipolar Disorders, and the Annals of General Psychiatry among others, approximately 15,000 citations and h=59 (Publish or Perish).
During the years 2016-8 he was ranked by expertscape.com within the top 25 world experts concerning Bipolar disorder (0.068%) and among the top 50 concerning suicidality (0.097%). In 2021 he was placed among the 0.37% for year and 0.57% for the whole career of all scientists of all disciplines by the Stanford ranking.
Organization
MSC ‘CLINICAL MENTAL HEALTH’
SCHOOL OF MEDICINE
FACULTY OF HEALTH SCIENCES
ARISTOTLE UNIVERSITY OF THESSALONIKI GREECE
In collaboration with
WPA 2020-23 Action Plan group on Evidence Based Psychopharmacology
WPA section on Evidence Based Psychiatry
